Thrombosis
News
Risks scream caution for catheter-directed thrombolysis for proximal DVT
Key clinical point: Catheter-directed thrombolysis carries higher risks and may not improve outcomes for proximal DVT patients. Major finding: In-...
Conference Coverage
ADSORB 1-year results show efficacy of endografting in type B aortic dissection
A significantly higher percentage of patients achieved false lumen thrombosis in the best medical therapy plus stent group, compared with those...
Conference Coverage
Device positioning may be culprit behind post-LVAD pump thrombosis
Key clinical point: Cannula malpositioning may be related to pump thrombosis after LVAD placement.Major finding: The rate of pump thrombosis after...
Conference Coverage
Resuming aspirin for cardioprotection after GI bleed tied to 38% cut in CV risk
Key clinical point: What’s the risk/benefit balance in restarting low-dose aspirin for secondary cardioprevention following a lower GI bleed? New...
News
UPDATED: FDA-released safety data on dabigatran vs. warfarin reassuring
Major finding: The risks of ischemic stroke, intracranial hemorrhage, and death associated with dabigatran treatment were lower than with warfarin...
Conference Coverage
Apixaban for VTE reduced subsequent hospitalizations
Major finding: Patients whose acute venous thromboembolism was treated with 6 months of apixaban were 21% less likely to have another...
Conference Coverage
Apixaban for VTE reduced subsequent hospitalizations
Major finding: Patients whose acute venous thromboembolism was treated with 6 months of apixaban were 21% less likely to have another...
News
INR test strips recalled due to reports of inaccurate results
Conference Coverage
Rivaroxaban replacing warfarin for AF stroke protection
Major finding: Rivaroxaban use grew from approximately 8% of AF patients in 2011 to 16% in 2012 and 30% in 2013.Data source: Review of...
News
Mortality nearly halved with dual antiplatelet therapy in severe PAD
Major finding: Patients with severe peripheral artery disease who were on dual antiplatelet therapy had an adjusted 45% reduction in the 3-year...
Conference Coverage
Despite VTE prophylaxis, more bleeds, no benefit in medical inpatients
Major finding: As VTE prophylaxis climbed from 59.2% to 77.9% over 2-plus years, the rate of symptomatic VTEs held steady at 0.56%, but major...